Médica Sur. de Past Earnings Performance
Past criteria checks 5/6
Médica Sur. de has been growing earnings at an average annual rate of 25%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 3.4% per year. Médica Sur. de's return on equity is 27.4%, and it has net margins of 13.5%.
Key information
25.0%
Earnings growth rate
27.9%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 3.4% |
| Return on equity | 27.4% |
| Net Margin | 13.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Does Médica Sur. de (BMV:MEDICAB) Have A Healthy Balance Sheet?
Dec 19
Is Médica Sur. de (BMV:MEDICAB) A Risky Investment?
Aug 30A Look At The Fair Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)
Jun 02Why We Like The Returns At Médica Sur. de (BMV:MEDICAB)
Dec 03Investors Shouldn't Overlook Médica Sur. de's (BMV:MEDICAB) Impressive Returns On Capital
Jun 07These 4 Measures Indicate That Médica Sur. de (BMV:MEDICAB) Is Using Debt Safely
May 09A Look At The Intrinsic Value Of Médica Sur, S.A.B. de C.V. (BMV:MEDICAB)
Apr 18Médica Sur, S.A.B. de C.V.'s (BMV:MEDICAB) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Mar 07Can You Imagine How Médica Sur. de's (BMV:MEDICAB) Shareholders Feel About The 74% Share Price Increase?
Feb 07
Médica Sur. de (BMV:MEDICAB) Has A Pretty Healthy Balance Sheet
Jan 17Could The Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Ownership Structure Tell Us Something Useful?
Dec 26Médica Sur, S.A.B. de C.V. (BMV:MEDICAB) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Nov 29Revenue & Expenses BreakdownBeta
How Médica Sur. de makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4,130 | 558 | 869 | 0 |
| 30 Sep 23 | 4,014 | 530 | 825 | 0 |
| 30 Jun 23 | 4,057 | 468 | 839 | 0 |
| 31 Mar 23 | 3,972 | 482 | 789 | 0 |
| 31 Dec 22 | 3,868 | 473 | 751 | 0 |
| 30 Sep 22 | 3,892 | 363 | 759 | 0 |
| 30 Jun 22 | 3,895 | 367 | 775 | 0 |
| 31 Mar 22 | 3,934 | 350 | 773 | 0 |
| 31 Dec 21 | 3,812 | 358 | 719 | 0 |
| 30 Sep 21 | 3,066 | 489 | 528 | 0 |
| 30 Jun 21 | 3,297 | 527 | 522 | 0 |
| 31 Mar 21 | 3,207 | 462 | 500 | 0 |
| 31 Dec 20 | 3,143 | 339 | 520 | 0 |
| 30 Sep 20 | 3,917 | 314 | 708 | 0 |
| 30 Jun 20 | 3,613 | 157 | 666 | 0 |
| 31 Mar 20 | 3,713 | 154 | 718 | 0 |
| 31 Dec 19 | 2,748 | 201 | 514 | 0 |
| 30 Sep 19 | 3,666 | 108 | 706 | 0 |
| 30 Jun 19 | 3,662 | 134 | 715 | 0 |
| 31 Mar 19 | 3,634 | 158 | 716 | 0 |
| 31 Dec 18 | 3,608 | 156 | 730 | 0 |
| 30 Sep 18 | 3,565 | 246 | 686 | 0 |
| 30 Jun 18 | 3,481 | 250 | 670 | 0 |
| 31 Mar 18 | 3,442 | 254 | 678 | 0 |
| 31 Dec 17 | 3,431 | 256 | 663 | 0 |
| 30 Sep 17 | 3,358 | 108 | 812 | 0 |
| 30 Jun 17 | 3,096 | 88 | 772 | 0 |
| 31 Mar 17 | 2,873 | 99 | 702 | 0 |
| 31 Dec 16 | 2,510 | 150 | 565 | 0 |
| 30 Sep 16 | 2,314 | 256 | 382 | 0 |
| 30 Jun 16 | 2,318 | 274 | 358 | 0 |
| 31 Mar 16 | 2,315 | 270 | 358 | 0 |
| 31 Dec 15 | 2,279 | 241 | 359 | 0 |
| 30 Sep 15 | 2,254 | 255 | 347 | 0 |
| 30 Jun 15 | 2,255 | 304 | 327 | 0 |
| 31 Mar 15 | 2,259 | 306 | 329 | 0 |
| 31 Dec 14 | 2,292 | 349 | 318 | 0 |
| 30 Sep 14 | 2,326 | 403 | 307 | 0 |
| 30 Jun 14 | 2,309 | 382 | 302 | 0 |
| 31 Mar 14 | 2,278 | 376 | 302 | 0 |
| 31 Dec 13 | 2,256 | 380 | 300 | 0 |
| 30 Sep 13 | 2,225 | 346 | 293 | 0 |
| 30 Jun 13 | 2,197 | 340 | 296 | 0 |
Quality Earnings: MEDICA B has high quality earnings.
Growing Profit Margin: MEDICA B's current net profit margins (13.5%) are higher than last year (12.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MEDICA B's earnings have grown significantly by 25% per year over the past 5 years.
Accelerating Growth: MEDICA B's earnings growth over the past year (18%) is below its 5-year average (25% per year).
Earnings vs Industry: MEDICA B earnings growth over the past year (18%) exceeded the Healthcare industry 17.9%.
Return on Equity
High ROE: MEDICA B's Return on Equity (27.4%) is considered high.